Embryome Sciences, Inc. Acquires Exclusive License for ACTC

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Reply to topic
Embryome Sciences, Inc. Acquires Exclusive License for ACTC
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Reply with quote


ALAMEDA, Calif.----Embryome Sciences, Inc., a wholly owned subsidiary of BioTime, Inc., has acquired from Advanced Cell Technology, Inc. an exclusive license to use “ACTCellerate™” embryonic stem cell technology and a bank of over 140 diverse progenitor cell lines derived using that technology.

Read more...
View user's profileSend private message
Embryome Sciences, Inc. Acquires Exclusive License for ACTC
All times are GMT - 7 Hours  
Page 1 of 1  

  
  
 Reply to topic  
Forum Map
Site Map